Medigen Vaccine Biologics Corp. said Sunday it will soon apply to the Food and Drug Administration in Taiwan and other countries for new drug approval for its enterovirus 71 (EV71) vaccine, as it has successfully completed its Phase III clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Potatoes from U.S. intercepted over excessive glycoalkaloids
10/06/2026 04:09 PM - Business
U.S. dollar closes lower on Taipei forex market
10/06/2026 04:09 PM - Politics
Ex-President Tsai arrives in San Francisco to warm welcome
10/06/2026 03:46 PM - Business
AMD to expand Taiwan supply chain investment as chip demand grows: Lisa Su
10/06/2026 02:59 PM - Society